Skip to main content
Panel releases new time-in-range recommendations for CGM use

A panel convened by the Advanced Technologies & Treatments for Diabetes Congress issued new time-in-range recommendations for type 1 and type 2 diabetes patients using a continuous glucose monitoring device. The recommendations, presented at the American Diabetes Association annual meeting and published in Diabetes Care, cover most diabetes patients, pregnant or older patients or those at high hypoglycemia risk.

Full Story: